Left Atrial Appendage Occlusion With the LAmbre Device: First-in-Human in the United States

Authors

Mohammed Qintar, Henry Ford HealthFollow
Dee Dee Wang, Henry Ford HealthFollow
James Lee, Henry Ford HealthFollow
Marvin H. Eng, Henry Ford HealthFollow
Tiberio Frisoli, Henry Ford HealthFollow
Pedro Villablanca, Henry Ford HealthFollow
William W. O'Neill, Henry Ford HealthFollow
Brian P. O'Neill, Henry Ford HealthFollow

Recommended Citation

Qintar M, Wang DD, Lee J, Eng MH, Frisoli T, Villablanca P, O'Neill WW, and O'Neill B. Left Atrial Appendage Occlusion With the LAmbre Device: First-in-Human in the United States. J Invasive Cardiol 2021; 33(8):E670-e671.

Document Type

Article

Publication Date

8-1-2021

Publication Title

The Journal of invasive cardiology

Abstract

The left atrial appendage (LAA) is a highly variable anatomical structure, which may pose a challenge to successful LAA occlusion with currently approved technology. We present our experience with the compassionate use of the LAmbre LAA closure device (Lifetecha) for a 79-year-old male patient with non-valvular atrial fibrillation and multiple falls who was considered high risk for anticoagulation therapy.

PubMed ID

34338657

Volume

33

Issue

8

First Page

670

Last Page

670